MacroGenics Inc logo

MGNX

NASDAQ

MacroGenics Inc

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$195.12M
P/E RatioN/A
Div. Yield
EPS (TTM)-$1.18
52W High$3.54
52W Low$0.99
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees293
Price Performance
1 Week+4.78%
3 Month+78.49%
1 Year+166.96%
FinancialsAnnual · QuiverQuant
Revenue$58.75M
Assets$298.42M
Liabilities$145.81M
Net Income$9.06M loss

About

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States. The company is headquartered in Rockville, Maryland.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze MGNX with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.